ADMA Biologics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Rok finansowy 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 1 3 6 7 11 23 17 29 42 81 154 258 426
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% inf% 174.4% 92.8% 21.3% 48.5% 113.5% -25.4% 72.8% 43.9% 91.7% 90.4% 67.6% 65.2%
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 40.2% 34.0% 36.7% 39.9% 40.3% -28.1% -148.4% -34.6% -45.2% 1.4% 22.9% 34.2% 51.5%
EBIT (mln) -30 -25 -20 -0 -0 -8 -15 -16 -16 -17 -39 -60 -41 -65 -58 -39 22 139
EBIT Δ r/r 0.0% -16.2% -19.6% -99.9% 28.9% 29786.5% 90.2% 6.5% -3.2% 11.7% 126.8% 53.4% -31.3% 56.7% -10.1% -32.6% -155.0% 542.5%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% -707.4% -490.4% -270.8% -216.1% -162.6% -172.7% -354.9% -141.1% -153.8% -72.1% -25.5% 8.4% 32.6%
Koszty finansowe (mln) 0 0 0 0 0 0 1 1 2 2 3 6 9 12 13 19 25 -14
EBITDA (mln) -30 -25 -20 -0 -0 -8 -15 -16 -15 -17 -37 -57 -40 -64 -58 -39 30 139
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% -689.2% -480.6% -271.8% -209.1% -157.6% -163.4% -334.3% -136.3% -151.7% -71.5% -25.5% 11.6% 32.6%
Podatek (mln) 0 0 0 -0 -0 -1 0 -1 2 2 4 5 9 12 13 19 0 -72
Zysk Netto (mln) -30 -25 -20 -0 -0 -7 -16 -17 -18 -20 -44 -66 -57 -88 -84 -85 -28 198
Zysk netto Δ r/r 0.0% -16.2% -19.6% -99.9% 28.9% 27493.8% 112.7% 8.3% 6.9% 8.6% 124.2% 50.2% -13.2% 53.6% -3.6% 0.9% -66.8% -800.0%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% -653.0% -506.2% -284.2% -250.4% -183.1% -192.3% -387.1% -194.4% -207.5% -104.3% -55.3% -10.9% 46.4%
EPS -11.87 -9.96 -8.0 -0.0082 -0.0106 -1.39 -2.38 -1.81 -1.73 -1.61 -1.91 -1.45 -1.05 -1.02 -0.61 -0.43 -0.13 0.85
EPS (rozwodnione) -11.87 -9.96 -8.0 -0.0082 -0.0106 -1.39 -2.38 -1.81 -1.73 -1.61 -1.91 -1.45 -1.05 -1.02 -0.61 -0.43 -0.13 0.81
Ilośc akcji (mln) 2 2 2 2 2 5 7 9 10 12 23 45 54 86 140 198 224 233
Ważona ilośc akcji (mln) 2 2 2 2 2 5 7 9 10 12 23 45 54 86 140 198 224 243
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD